Immediate Versus Delayed FET Following a Stimulated IVF Cycle

A Randomized Trial Comparing the Effect of Immediate Versus Delayed Frozen-thawed Embryo Transfer Following a Stimulated IVF Cycle

Information regarding the optimal timing for frozen-thawed embryo transfer (FET) following a stimulated in vitro fertilization (IVF) is lacking. One option is to perform FET in the first cycle following the stimulated IVF cycle, i.e. immediate transfer. Another option is to postpone FET for at least one menstrual cycle, i.e. delayed transfer. This randomized study aims to compare the ongoing pregnancy rate of immediate versus delayed FET following a stimulated IVF cycle.

Study Overview

Study Type

Interventional

Enrollment (Actual)

724

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Shanghai, China
        • ShangHai JIAI Genetics&IVF Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 43 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women aged ≤43 years at the time of IVF/ICSI treatment Undergoing IVF with a standard stimulation At least one frozen embryo or blastocyst The first FET cycle following ovarian stimulation in IVF/ICSI

Exclusion Criteria:

  • Use of mild stimulation or natural cycle for IVF/ICSI treatment Severe ovarian hyperstimulation syndrome during IVF/ICSI treatment Preimplantation genetic diagnosis treatment Use of donor oocytes Presence of hydrosalpinx which is not surgically treated or endometrial polyp on scanning during ovarian stimulation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: immediate group
the intervention: immediate frozen-thawed embryo transfer (FET) which means FET will be performed in the first cycle following the stimulated IVF cycle
Frozen-thawed embryo transfer will be performed in the first cycle following the stimulated IVF cycle
Other: delayed group
the intervention: delayed frozen-thawed embryo transfer (FET) which means FET will be performed at least in the second cycle following the stimulated IVF cycle
Frozen-thawed embryo transfer will be performed at least in the second cycle following the stimulated IVF cycle

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ongoing pregnancy
Time Frame: viable pregnancy beyond gestation 12 weeks
viable pregnancy beyond gestation 12 weeks
viable pregnancy beyond gestation 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
multiple pregnancy
Time Frame: multiple pregnancy beyond gestation 12 weeks
more than one intrauterine sacs on scanning
multiple pregnancy beyond gestation 12 weeks
ectopic pregnancy
Time Frame: ectopic pregnancy during 12 weeks gestation
pregnancy outside the uterine cavity
ectopic pregnancy during 12 weeks gestation
clinical pregnancy
Time Frame: presence of intrauterine gestational sac on ultrasound at 6 weeks of pregnancy
presence of intrauterine gestational sac on ultrasound
presence of intrauterine gestational sac on ultrasound at 6 weeks of pregnancy
implantation rate
Time Frame: number of gestational sacs per embryo transferred during 4 weeks of pregnancy
number of gestational sacs per embryo transferred
number of gestational sacs per embryo transferred during 4 weeks of pregnancy
miscarriage
Time Frame: the loss of a pregnancy before 22 weeks gestation
the loss of a pregnancy before 22 weeks gestation
the loss of a pregnancy before 22 weeks gestation
birth weight
Time Frame: a live birth after 22 weeks gestation
birth weight of the baby delivered
a live birth after 22 weeks gestation
Positive hCG level
Time Frame: A blood pregnancy test is performed 14 days after the FET
the result of serum β-hCG ≥10 mIU/mL.
A blood pregnancy test is performed 14 days after the FET
biochemical pregnancy:
Time Frame: positive blood pregnancy test not followed by clinical pregnancy during 12 weeks gestation
positive blood pregnancy test not followed by clinical pregnancy
positive blood pregnancy test not followed by clinical pregnancy during 12 weeks gestation
live birth rate
Time Frame: a live birth after 22 weeks gestation
the rate of live births per cycle
a live birth after 22 weeks gestation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: XIAOXI SUN, PHD, Shanghai JiAi Genetics & IVF Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 9, 2017

Primary Completion (Actual)

March 4, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

June 23, 2017

First Submitted That Met QC Criteria

June 26, 2017

First Posted (Actual)

June 28, 2017

Study Record Updates

Last Update Posted (Actual)

May 14, 2020

Last Update Submitted That Met QC Criteria

May 13, 2020

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • ShangHaiIVG

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data that underlie the results after deidentification (text, tables, figures, and appendices) and study protocol will be shared. Data will be available when beginning 3 months and ending 5 years following article publication. To achieve aims in the approved proposal, researchers who provide a methodologically sound proposal will be shared with.Data will be made available by the following way. Proposals should be directed to lihe198900@163.com. And data are available for 5 years at a third party website (link to be included after the article publication).

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Embryo Transfer

Clinical Trials on immediate frozen-thawed embryo transfer

Subscribe